Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Dow
AstraZeneca
Healthtrust
Express Scripts
Federal Trade Commission
Queensland Health
Colorcon

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,309,442

« Back to Dashboard

Title: Method for controlling fertility in mammals
Abstract:A method for preventing gestation in mammals comprising the administration of a 2,5-diamino-2-halomethylpentanoic acid or derivative thereof.
Inventor(s): Bey; Philippe (Strasbourg, FR), Jung; Michel (Illkirch Graffenstaden, FR)
Assignee: Merrell Toraude et Compagnie (Strasbourg, FR)
Filing Date:Dec 03, 1980
Application Number:06/212,473
Claims:1. A method of preventing gestation in mammals which comprises the administration to said mammals of a contragestationally effective amount of a compound of the formula: ##STR14## wherein: Y is FCH.sub.2 --, F.sub.2 CH--, or F.sub.3 C--;

R.sub.a and R.sub.b are, independently, hydrogen, (C.sub.1 -C.sub.4)alkylcarbonyl, or the group ##STR15## wherein R.sub.2 is hydrogen, (C.sub.1 -C.sub.4) alkyl, benzyl, or p-hydroxybenyl;

R.sub.1 is hydroxy, (C.sub.1 -C.sub.8) alkoxy, the group --NR.sub.4 R.sub.5, wherein R.sub.4 and R.sub.5 are, independently, hydrogen, or, (C.sub.1 -C.sub.4)alkyl, or the group ##STR16## wherein R.sub.3 is hydrogen, (C.sub.1 -C.sub.4) alkyl, benzyl, or p-hydroxybenzyl; and the pharmaceutically acceptable salts and individual optical isomers thereof.

2. A method as defined in claim 1 wherein Y is --CH.sub.2 F or --CHF.sub.2.

3. A method as defined in claim 1 or 2 wherein R.sub.1 is hydroxy.

4. A method as defined in claim 1 or 2 wherein R.sub.1 is hydroxy and R.sub.a is hydrogen.

5. A method as defined in claim 1 or 2 wherein R.sub.1 is hydroxy and R.sub.b is hydrogen.

6. A method as defined in claim 1 or 2 wherein R.sub.a and R.sub.b are hydrogen.

7. A method as defined in claim 2 which comprises the administration of 2,5-diamino-2-fluoromethylpentanoic acid.

8. A method as defined in claim 2 which comprises the administration of 2,5-diamino-2-diamino-2-difluoromethylpentanoic acid.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
Dow
Teva
McKesson
US Department of Justice
Colorcon
Cerilliant
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.